271 related articles for article (PubMed ID: 25073966)
1. The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children.
Kazankov K; Møller HJ; Lange A; Birkebaek NH; Holland-Fischer P; Solvig J; Hørlyck A; Kristensen K; Rittig S; Handberg A; Vilstrup H; Grønbaek H
Pediatr Obes; 2015 Jun; 10(3):226-33. PubMed ID: 25073966
[TBL] [Abstract][Full Text] [Related]
2. Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.
Rødgaard-Hansen S; St George A; Kazankov K; Bauman A; George J; Grønbæk H; Jon Møller H
Scand J Clin Lab Invest; 2017 Nov; 77(7):498-504. PubMed ID: 28715286
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
4. The macrophage activation product sCD163 is associated with a less favourable metabolic profile in prepubertal children.
Carreras-Badosa G; Prats-Puig A; Diaz-Roldan F; Platero-Gutierrez E; Osiniri I; Riera-Perez E; de Zegher F; Ibañez L; Bassols J; López-Bermejo A
Pediatr Obes; 2016 Dec; 11(6):543-550. PubMed ID: 26843034
[TBL] [Abstract][Full Text] [Related]
5. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.
Kazankov K; Barrera F; Møller HJ; Rosso C; Bugianesi E; David E; Younes R; Esmaili S; Eslam M; McLeod D; Bibby BM; Vilstrup H; George J; Grønbaek H
Liver Int; 2016 Oct; 36(10):1549-57. PubMed ID: 27102725
[TBL] [Abstract][Full Text] [Related]
6. The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.
Fjeldborg K; Christiansen T; Bennetzen M; J Møller H; Pedersen SB; Richelsen B
Obesity (Silver Spring); 2013 Dec; 21(12):2437-43. PubMed ID: 23512476
[TBL] [Abstract][Full Text] [Related]
7. Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease.
Kazankov K; Alisi A; Møller HJ; De Vito R; Rittig S; Mahler B; Nobili V; Grønbæk H
J Pediatr Gastroenterol Nutr; 2018 Nov; 67(5):635-642. PubMed ID: 30074574
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
Kazankov K; Barrera F; Møller HJ; Bibby BM; Vilstrup H; George J; Grønbaek H
Hepatology; 2014 Aug; 60(2):521-30. PubMed ID: 24623375
[TBL] [Abstract][Full Text] [Related]
11. Sleep Duration and Media Time Have a Major Impact on Insulin Resistance and Metabolic Risk Factors in Obese Children and Adolescents.
Sayin FK; Buyukinan M
Child Obes; 2016 Aug; 12(4):272-8. PubMed ID: 26978730
[TBL] [Abstract][Full Text] [Related]
12. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population.
Villanueva-Ortega E; Garcés-Hernández MJ; Herrera-Rosas A; López-Alvarenga JC; Laresgoiti-Servitje E; Escobedo G; Queipo G; Cuevas-Covarrubias S; Garibay-Nieto GN
Ann Hepatol; 2019; 18(5):693-700. PubMed ID: 31151875
[TBL] [Abstract][Full Text] [Related]
13. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
[TBL] [Abstract][Full Text] [Related]
14. Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects.
Zanni MV; Burdo TH; Makimura H; Williams KC; Grinspoon SK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):385-90. PubMed ID: 22098563
[TBL] [Abstract][Full Text] [Related]
15. Macrophage activation, age and sex effects of immunometabolism in obese asthma.
Periyalil HA; Wood LG; Scott HA; Jensen ME; Gibson PG
Eur Respir J; 2015 Feb; 45(2):388-95. PubMed ID: 25186264
[TBL] [Abstract][Full Text] [Related]
16. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
Lidofsky A; Holmes JA; Feeney ER; Kruger AJ; Salloum S; Zheng H; Seguin IS; Altinbas A; Masia R; Corey KE; Gustafson JL; Schaefer EA; Hunt PW; Deeks S; Somsouk M; Chew KW; Chung RT; Alatrakchi N
J Infect Dis; 2018 Sep; 218(9):1394-1403. PubMed ID: 29868909
[TBL] [Abstract][Full Text] [Related]
17. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function.
Semnani-Azad Z; Connelly PW; Johnston LW; Retnakaran R; Harris SB; Zinman B; Hanley AJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):e285-94. PubMed ID: 31677389
[TBL] [Abstract][Full Text] [Related]
18. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD163-Associated Dietary Patterns and the Risk of Metabolic Syndrome.
Hu TY; Lee SY; Shih CK; Chou MJ; Wu MC; Teng IC; Bai CH; Sabrina N; Tinkov AA; Skalny AV; Chang JS
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31027316
[TBL] [Abstract][Full Text] [Related]
20. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.
Björklund J; Laursen TL; Sandahl TD; Møller HJ; Vilstrup H; Ott P; Grønbæk H
Orphanet J Rare Dis; 2018 Sep; 13(1):169. PubMed ID: 30241550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
